Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element
Yi Luo, Alan R. Tall
Yi Luo, Alan R. Tall
View: Text | PDF
Article

Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element

  • Text
  • PDF
Abstract

The cholesterol ester transfer protein (CETP) facilitates the transfer of HDL cholesterol esters from plasma to the liver. Transgenic mice expressing human CETP, controlled by its natural flanking region, increase expression of this gene in response to hypercholesterolemia. We established a CETP promoter-luciferase reporter assay in differentiated 3T3-L1 adipocytes to map the sterol upregulatory element. Promoter mutagenesis suggested that a direct repeat of a nuclear receptor binding sequence separated by 4 nucleotides (DR4 element, –384 to –399) was responsible for this activity. Using mice carrying normal or mutated promoter sequences, we confirmed the importance of this element for gene induction by dietary sterol. A gel retardation complex containing LXR/RXR was identified using the CETP DR4 element and adipocyte nuclear extracts. Both LXRα/RXRα and LXRβ/RXRα transactivated the CETP promoter via its DR4 element in a sterol-responsive fashion. Thus, the positive sterol response of the CETP gene is mediated by a nuclear receptor binding site that is activated by LXRs. That Cyp7a, the rate-limiting enzyme for conversion of cholesterol into bile acids in the liver, is also regulated by LXRα suggests that this class of nuclear receptor coordinates the regulation of HDL cholesterol ester catabolism and bile acid synthesis in the liver.

Authors

Yi Luo, Alan R. Tall

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
(a) Gel mobility shift analysis to identify the proteins that bind to th...
(a) Gel mobility shift analysis to identify the proteins that bind to the DR4 element in the CETP promoter. A 24-bp fragment containing the CETP DR4 (cpDR4) (–380 to –403) was labeled and incubated with nuclear extracts from differentiated 3T3-L1 adipocytes in the presence of excess F2 fragment (CETP DR4 half site) to abolish nonspecific factors binding to the DR4 half site. Various cold competitor fragments were included as indicated, and shifted bands were resolved in a 5% polyacrylamide gel. F6 consists of only the 5′ half site and spacing region of the DR4 element. M1–M5 mutations are shown in Figure 3b. The arrow indicates the P1 complex. (b) The protein complex binding to the CETP DR4 contains an LXR/RXR heterodimer. Gel shift experiments were carried out in the absence (lane 1) or presence of 2 μg polyclonal antibodies against LXRα/β, LXRα, or RXRα (lanes 2–4), or RORα (lane 5). The arrow indicates the P1 band. The bands supershifted by RXRα or LXR antibodies are indicated by thick arrows.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts